| __timestamp | Jazz Pharmaceuticals plc | Regeneron Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 117418000 | 205018000 |
| Thursday, January 1, 2015 | 102526000 | 392709000 |
| Friday, January 1, 2016 | 105386000 | 299694000 |
| Sunday, January 1, 2017 | 110188000 | 397061000 |
| Monday, January 1, 2018 | 121544000 | 434100000 |
| Tuesday, January 1, 2019 | 127930000 | 782200000 |
| Wednesday, January 1, 2020 | 148917000 | 1119900000 |
| Friday, January 1, 2021 | 440760000 | 2437500000 |
| Saturday, January 1, 2022 | 540517000 | 1560400000 |
| Sunday, January 1, 2023 | 435577000 | 1815800000 |
Infusing magic into the data realm
In the competitive landscape of pharmaceuticals, understanding cost structures is crucial. Over the past decade, Regeneron Pharmaceuticals, Inc. and Jazz Pharmaceuticals plc have showcased distinct trajectories in their cost of revenue. From 2014 to 2023, Regeneron's cost of revenue surged by approximately 785%, peaking in 2021. This reflects their aggressive expansion and investment in research and development. In contrast, Jazz Pharmaceuticals experienced a more modest increase of around 271% during the same period, with a notable spike in 2021, indicating strategic scaling and operational efficiency.
Regeneron's cost of revenue consistently outpaced Jazz's, highlighting its larger scale and broader market reach. The data reveals a pivotal year in 2021, where both companies saw significant increases, possibly due to market dynamics or strategic shifts. This comparison underscores the diverse strategies employed by pharmaceutical leaders to navigate the ever-evolving healthcare landscape.
Cost Insights: Breaking Down Merck & Co., Inc. and Jazz Pharmaceuticals plc's Expenses
Cost Insights: Breaking Down Amgen Inc. and Regeneron Pharmaceuticals, Inc.'s Expenses
Cost of Revenue: Key Insights for Regeneron Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Limited
Cost Insights: Breaking Down Regeneron Pharmaceuticals, Inc. and Biogen Inc.'s Expenses
Comparing Cost of Revenue Efficiency: Regeneron Pharmaceuticals, Inc. vs Geron Corporation
Cost of Revenue: Key Insights for Neurocrine Biosciences, Inc. and Jazz Pharmaceuticals plc
BioMarin Pharmaceutical Inc. vs Jazz Pharmaceuticals plc: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Sarepta Therapeutics, Inc. and Jazz Pharmaceuticals plc
Comparing Cost of Revenue Efficiency: Walgreens Boots Alliance, Inc. vs Jazz Pharmaceuticals plc
Cost of Revenue Trends: Jazz Pharmaceuticals plc vs Grifols, S.A.
Cost of Revenue Comparison: Jazz Pharmaceuticals plc vs MorphoSys AG
Jazz Pharmaceuticals plc vs Amphastar Pharmaceuticals, Inc.: Efficiency in Cost of Revenue Explored